sulodexide
Trade name: Aterina
Small moleculeexperimental
Sulodexide, traded as Aterina, is a highly purified mixture of glycosaminoglycans composed of heparan sulfate (80%) and dermatan sulfate (20%). — Wikipedia
Clinical trial activity
20 trials · 25 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
10
Phase 3
9
Phase 4
5
Earliest trial started Aug 1, 2005 (NCT00130208)
Timeline
Indications
Approved for
Studied for
- Aged · Phase 3
- Albuminuria · Phase 4
- Anticoagulants · Phase 3
- COVID-19 · Phase 4
- Diabetes Mellitus · Phase 4
- Diabetic Nephropathies · Phase 4
- Diabetic Retinopathy · Phase 2
- Drug Therapy · Phase 3
- Endothelial Cells · Phase 4
- Glomerulonephritis, Membranoproliferative · Phase 1
- Inflammation · Phase 4
- Minimally Invasive Surgical Procedures · Phase 3
- Peripheral Arterial Disease · Phase 3
- Postthrombotic Syndrome · Phase 4
- Prostatic Diseases · Phase 3
- Prostatic Hyperplasia · Phase 3
- Psoriasis · Phase 3
- Randomized Controlled Trial · Phase 3
- Renal Insufficiency, Chronic · Phase 3
- Thrombosis · Phase 4
- Tinnitus · Phase 2
- Venous Thromboembolism · Phase 3
Mechanism of action
- Tissue-type plasminogen activatorACTIVATOR
PLAT activator
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaSulodexide ↗
- ChEMBLCHEMBL2108086 ↗
Also known as
- 3-glucosaminoglycan sulfate
- aterina
- glucuronyl glucosamine glycan sulfate
- glucuronyl glucosaminoglycan sulfate
- glucuronylglucosaminoglycan sulfate
- luzone
- sulodexide
- sulodexide
- sulodexide
- sulodexide
- sulodexide
- sulodexide
- sulodexide
- vessel
- vessel
- vessel (polysaccharide)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06982196 | Phase 3 | Apr 20, 2025 | Xijing Hospital |
| NCT05654233 | N/A | Feb 1, 2023 | Chengdu University of Traditional Chinese Medicines |
| NCT05371925 | Phase 3 | Jul 26, 2022 | Alfasigma S.p.A., Centro Medico del Noroeste |
| NCT05252923 | Phase 4 | Apr 1, 2022 | Pirogov Russian National Research Medical University |
| NCT04245566 | Phase 3 | Dec 31, 2020 | Cantonal Hospital of St. Gallen |
| NCT04483830 | Phase 2/Phase 3 (Phase 3) | Jun 5, 2020 | Alfasigma S.p.A. |
| NCT04257487 | Phase 3 | May 2, 2020 | Arianna Anticoagulazione Foundation, Vita-Salute University of Milano. Italy |
| NCT04180137 | N/A | Nov 28, 2019 | Pirogov Russian National Research Medical University |
| NCT03370705 | Phase 3 | Sep 1, 2018 | Alfa Wassermann, Poseidon CRO |
| NCT03504566 | Phase 4 | Nov 15, 2017 | Steno Diabetes Center Copenhagen, University of Groningen |
| NCT03511534 | N/A | Jun 23, 2017 | Stanford University |
| NCT02512601 | Phase 4 | Sep 1, 2015 | Alfasigma S.p.A., Hospital de Mataró |
| NCT02737670 | Phase 2 | Aug 1, 2014 | St Joseph University, St Joseph University of Beirut |
| NCT01316068 | Phase 4 | Mar 1, 2011 | Sun Yat-Sen University |
| NCT01000545 | Phase 3 | Nov 1, 2009 | Alfa Wassermann, Corbridge Group Philippines, Inc. |
| NCT01295775 | Phase 2 | Feb 1, 2009 | Ajou University, Hallym University |
| NCT00583427 | Phase 1 | Dec 1, 2007 | University of Iowa |
| NCT00462202 | Phase 3 | Apr 1, 2007 | Keryx, Monash University |
| NCT00130312 | Phase 4 | Aug 1, 2005 | Hebrew University, Keryx, Monash University, Rush University, University of Groningen |
| NCT00130208 | Phase 3 | Aug 1, 2005 | Hebrew University, Keryx, Monash University, Rush University, University of Groningen |
Showing 20 of 20 trials
Page 1 / 1
Organizations
Research & Development (25)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alfasigma S.p.A. | For profit | 3 | 2 | 2 | 2015 |
| Keryx | For profit | 3 | 3 | 2 | 2005 |
| Monash University | Academic/Hospital | 3 | 0 | 2 | 2005 |
| University of Groningen | Academic/Hospital | 3 | 0 | 2 | 2005 |
| Alfa Wassermann | For profit | 2 | 1 | 1 | 2009 |
| Hebrew University | Academic/Hospital | 2 | 0 | 2 | 2005 |
| Pirogov Russian National Research Medical University | Academic/Hospital | 2 | 2 | 2 | 2019 |
| Rush University | Academic/Hospital | 2 | 0 | 2 | 2005 |
| Ajou University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Arianna Anticoagulazione Foundation | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Cantonal Hospital of St. Gallen | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Centro Medico del Noroeste | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Chengdu University of Traditional Chinese Medicines | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Corbridge Group Philippines, Inc. | For profit | 1 | 1 | 1 | 2009 |
| Hallym University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Hospital de Mataró | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Poseidon CRO | For profit | 1 | 0 | 1 | 2018 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Steno Diabetes Center Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2017 |
| St Joseph University | Academic/Hospital | 1 | 0 | 1 | 2014 |
25 organizations
Page 1 / 2